Elivaldogene Autotemcel Infusion Suppliers & Bulk Manufacturers
Available Forms: Intravenous infusion
Available Strengths: A personalized gene therapy designed to halt or slow ALD progression, dosed based on weight, administered as a single infusion in specialized treatment centers
Reference Brands: Skysona(US & EU)
Category: Cell & Gene Therapies
Elivaldogene autotemcel (Skysona) is a gene therapy that delivers a functional ABCD1 gene via viral vectors, halting or slowing adrenoleukodystrophy (ALD) progression. It reduces neurological decline, stabilizes cognitive function, and improves quality of life when administered early in specialized centers, offering long-term disease management.
Product Description:
Elivaldogene autotemcel (Skysona) is regulated in the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP and MDR standards. In the US, FDA approval involved extensive clinical validation, safety assessments, and comparability data. In the EU, CE marking certifies conformity with MDR requirements, with ongoing approval processes in some member states. These gene therapies undergo validation, stability testing, and audits, supported by comprehensive documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring regulatory compliance guarantees access to innovative treatments supporting early intervention in cerebral ALD worldwide.
Elivaldogene Autotemcel Infusion — third party manufacturing & bulk supply
Elivaldogene Autotemcel Infusion is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Elivaldogene Autotemcel Infusion is supplied as Intravenous infusion — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Elivaldogene Autotemcel Infusion listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Elivaldogene Autotemcel Infusion →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Darleukin Injection
Strength:
A standardized dose of 120 million adipose-derived stem cells per injection
Form: Intralesional injection
Reference Brands: Alofisel(US & EU)
View Details
Etranacogene Dezaparvovec. Infusion
Strength:
Single infusion product designed to produce sustained factor IX levels in hemophilia B patients, dosage individualized based on patient weight
Form: Intravenous infusion
Reference Brands: Hemgenix (US & EU)
View Details
Valoctocogene Roxaparvovec Infusion
Strength:
A single-dose gene therapy designed to increase factor VIII production in hemophilia A patients
Form: Intravenous infusion
Reference Brands: Roctavian(US & EU)
View Details
Voretigene Neparvovec Infusion
Strength:
Adeno-associated virus (AAV) vector administered via subretinal injection
Form: Subretinal injection
Reference Brands: Luxturna(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
